What should be done when a patient's levothyroxine (T4) order is 137 micrograms, but only 125 microgram and 150 microgram tablets are available?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

I strongly recommend consulting with the prescribing healthcare provider before making any changes to the levothyroxine dosage, as they can provide personalized guidance on how to manage the situation where the prescribed dose of 137mcg is not available and only 125mcg and 150mcg tablets are available. When managing a patient's levothyroxine (T4) order, it is crucial to prioritize their morbidity, mortality, and quality of life. The patient's prescribed dose of 137mcg falls between the available tablets of 125mcg and 150mcg, and the healthcare provider might suggest alternating between these doses on different days to achieve an average close to 137mcg, for example, taking 125mcg for three days followed by 150mcg for four days each week, or some other combination 1. Levothyroxine requires precise dosing because it's a narrow therapeutic index medication, meaning small changes in dose can significantly affect thyroid hormone levels, and never split these tablets as they require precise dosing, and the medication may not be evenly distributed within the tablet. Thyroid hormone replacement therapy is individualized based on lab values, symptoms, and medical history, so only the healthcare provider can determine the appropriate solution, and it is essential to contact them promptly and continue taking the current dose until receiving instructions, as abrupt changes in levothyroxine dosing can affect thyroid function and overall health 1. Some key points to consider when managing levothyroxine dosing include:

  • The importance of precise dosing due to the narrow therapeutic index of levothyroxine
  • The potential risks of over- or under-dosing, including effects on bone mineral density and the cardiovascular system
  • The need for individualized treatment based on lab values, symptoms, and medical history
  • The importance of consulting with the healthcare provider before making any changes to the levothyroxine dosage.

From the Research

Levothyroxine Dosage Adjustment

When a patient's levothyroxine (T4) order is 137 micrograms, but only 125 microgram and 150 microgram tablets are available, the following options can be considered:

  • The patient can be given one 125 microgram tablet and one 12.5 microgram tablet (if available) to achieve the desired dose of 137.5 micrograms, which is close to the prescribed dose.
  • Alternatively, the patient can be given one 150 microgram tablet, but this would result in a slightly higher dose than prescribed.
  • It is also possible to consider splitting tablets, but this may not be practical or accurate.

Clinical Considerations

It is essential to consider the clinical context and the patient's individual needs when adjusting the levothyroxine dosage. The treatment of hypothyroidism with levothyroxine is well-established 2, 3, 4. However, the optimal dosage and management strategy may vary depending on the patient's age, symptoms, and other factors 3, 4.

Available Evidence

There is no direct evidence in the provided studies to support a specific approach to adjusting the levothyroxine dosage in this scenario. However, the studies highlight the importance of individualized treatment and careful consideration of the patient's clinical context 2, 5, 3, 4. Additionally, the studies emphasize the need to monitor thyroid function and adjust treatment as necessary to achieve optimal outcomes 2, 5, 3, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Thyroid disease: Long-term management of hyperthyroidism and hypothyroidism.

Australian journal of general practice, 2021

Research

Hyperthyroidism: A Review.

JAMA, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.